<p><strong>Renal Impairment</strong>: No pharmacokinetic information is available on selegiline or its metabolites in renally impaired subjects.<br />
<br />
<strong>Hepatic Impairment</strong>: No pharmacokinetic information is available on selegiline or its metabolites in hepatically impaired subjects.<br />
<br />
<strong>Pediatric Use</strong>: The effects of selegiline hydrochloride in children have not been evaluated.</p>